These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 25650244)

  • 1. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
    Mahlokozera T; Vellimana AK; Li T; Mao DD; Zohny ZS; Kim DH; Tran DD; Marcus DS; Fouke SJ; Campian JL; Dunn GP; Miller CA; Kim AH
    Neuro Oncol; 2018 Mar; 20(4):472-483. PubMed ID: 29244145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.
    Favero F; McGranahan N; Salm M; Birkbak NJ; Sanborn JZ; Benz SC; Becq J; Peden JF; Kingsbury Z; Grocok RJ; Humphray S; Bentley D; Spencer-Dene B; Gutteridge A; Brada M; Roger S; Dietrich PY; Forshew T; Gerlinger M; Rowan A; Stamp G; Eklund AC; Szallasi Z; Swanton C
    Ann Oncol; 2015 May; 26(5):880-887. PubMed ID: 25732040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
    Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
    Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
    Umphlett M; Shea S; Tome-Garcia J; Zhang Y; Hormigo A; Fowkes M; Tsankova NM; Yong RL
    BMC Cancer; 2020 Jan; 20(1):47. PubMed ID: 31959133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
    Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
    J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunobiologic markers in primary and recurrent glioblastoma.
    Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D
    J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
    Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
    Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
    [No Abstract]   [Full Text] [Related]  

  • 9. Clonal evolution of glioblastoma under therapy.
    Wang J; Cazzato E; Ladewig E; Frattini V; Rosenbloom DI; Zairis S; Abate F; Liu Z; Elliott O; Shin YJ; Lee JK; Lee IH; Park WY; Eoli M; Blumberg AJ; Lasorella A; Nam DH; Finocchiaro G; Iavarone A; Rabadan R
    Nat Genet; 2016 Jul; 48(7):768-76. PubMed ID: 27270107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and functional diversity of propagating cells in glioblastoma.
    Piccirillo SGM; Colman S; Potter NE; van Delft FW; Lillis S; Carnicer MJ; Kearney L; Watts C; Greaves M
    Stem Cell Reports; 2015 Jan; 4(1):7-15. PubMed ID: 25533637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From astrocytoma to glioblastoma: a clonal evolution study.
    Yang F; Zou Y; Gong Q; Chen J; Li WD; Huang Q
    FEBS Open Bio; 2020 May; 10(5):744-751. PubMed ID: 32069381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing.
    Virk SM; Gibson RM; Quinones-Mateu ME; Barnholtz-Sloan JS
    PLoS One; 2015; 10(5):e0124178. PubMed ID: 25950952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of treatment-induced genomic alterations in gliomas.
    Erson-Omay EZ; Henegariu O; Omay SB; Harmancı AS; Youngblood MW; Mishra-Gorur K; Li J; Özduman K; Carrión-Grant G; Clark VE; Çağlar C; Bakırcıoğlu M; Pamir MN; Tabar V; Vortmeyer AO; Bilguvar K; Yasuno K; DeAngelis LM; Baehring JM; Moliterno J; Günel M
    Genome Med; 2017 Feb; 9(1):12. PubMed ID: 28153049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary dynamics of residual disease in human glioblastoma.
    Spiteri I; Caravagna G; Cresswell GD; Vatsiou A; Nichol D; Acar A; Ermini L; Chkhaidze K; Werner B; Mair R; Brognaro E; Verhaak RGW; Sanguinetti G; Piccirillo SGM; Watts C; Sottoriva A
    Ann Oncol; 2019 Mar; 30(3):456-463. PubMed ID: 30452544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.
    Nickel GC; Barnholtz-Sloan J; Gould MP; McMahon S; Cohen A; Adams MD; Guda K; Cohen M; Sloan AE; LaFramboise T
    PLoS One; 2012; 7(4):e35262. PubMed ID: 22536362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.
    Abou-El-Ardat K; Seifert M; Becker K; Eisenreich S; Lehmann M; Hackmann K; Rump A; Meijer G; Carvalho B; Temme A; Schackert G; Schröck E; Krex D; Klink B
    Neuro Oncol; 2017 Apr; 19(4):546-557. PubMed ID: 28201779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.
    Yoon N; Kim HS; Lee JW; Lee EJ; Maeng LS; Yoon WS
    Cancer Genomics Proteomics; 2020; 17(6):803-812. PubMed ID: 33099481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.